584 related articles for article (PubMed ID: 3309510)
41. The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.
Keuneke C; Yacullo R; Metzger R; Hellmann T; Peters J; Ganten D
Eur Heart J; 1990 May; 11 Suppl D():11-6. PubMed ID: 2163328
[TBL] [Abstract][Full Text] [Related]
42. Converting enzyme inhibition and modulation of plasma renin activity with captopril in anesthetized rats.
Suzuki M; Satoh S
Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):121-36. PubMed ID: 6275810
[TBL] [Abstract][Full Text] [Related]
43. Ultrafine carbon black attenuates the antihypertensive effect of captopril in spontaneously hypertensive rats.
Zhang X; Chen Y; Wei H; Qin Y; Hao Y; Zhu Y; Deng F; Guo X
Inhal Toxicol; 2014 Dec; 26(14):853-60. PubMed ID: 25472475
[TBL] [Abstract][Full Text] [Related]
44. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
Brown L; Duce B; Miric G; Sernia C
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S143-8. PubMed ID: 9892155
[TBL] [Abstract][Full Text] [Related]
45. Prostaglandin synthesis inhibitors potentiate the antihypertensive effect of heparin in spontaneously hypertensive rats.
Susic D; Mandal AK; Radujkovic G; Vulovic D; Kentera D
J Lab Clin Med; 1988 Jan; 111(1):63-72. PubMed ID: 3275731
[TBL] [Abstract][Full Text] [Related]
46. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
Edling O; Bao G; Feelisch M; Unger T; Gohlke P
J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177
[TBL] [Abstract][Full Text] [Related]
47. [Antihypertensive activity of the angiotensin converting enzyme inhibitor quinapril HCl: (S)-2-[(S)-N-[(S)-1-ethoxycarbonyl-3-phenylpropyl) alanyl]-1,2,3,4- tetrahydro-3-isoquinolinecarboxylic acid monohydrochloride in various hypertensive animal models].
Yaoka O; Aoki K; Nakajima T; Setoguchi M
Nihon Yakurigaku Zasshi; 1993 Jul; 102(1):35-45. PubMed ID: 8335286
[TBL] [Abstract][Full Text] [Related]
48. Antihypertensive, hemodynamic and autonomic profile of a new angiotensin converting enzyme inhibitor, SCH 33844 (spirapril).
Baum T; Watkins RW; Sybertz EJ; Ahn HS; Nelson S; Coleman W; Tedesco R; Pula KK; Rivelli M; Sabin C
Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):230-45. PubMed ID: 2884941
[TBL] [Abstract][Full Text] [Related]
49. Endothelin-1 upregulation in the kidney of uninephrectomized spontaneously hypertensive rats and its modification by the angiotensin-converting enzyme inhibitor quinapril.
Largo R; Gómez-Garre D; Liu XH; Alonso J; Blanco J; Plaza JJ; Egido J
Hypertension; 1997 May; 29(5):1178-85. PubMed ID: 9149684
[TBL] [Abstract][Full Text] [Related]
50. Antihypertensive action of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride in hypertensive rat models.
Tanaka M; Yamamoto S; Nakao K; Inukai T; Ogawa N; Katsumura H; Ohara N; Shukunobe K; Ono H
Arzneimittelforschung; 1991 Jun; 41(6):608-12. PubMed ID: 1930348
[TBL] [Abstract][Full Text] [Related]
51. Antihypertensive and angiotensin converting enzyme inhibitory activities of a novel dihydrobenzofuran analogue.
Hamilton TC; Howlett DR; Longman SD; Markwell RE; Norton J; Summers DR; Wilson C
Arzneimittelforschung; 1988 Apr; 38(4):531-6. PubMed ID: 2840917
[TBL] [Abstract][Full Text] [Related]
52. Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs.
Farina NK; Johnston CI; Burrell LM
J Hypertens; 2000 Jun; 18(6):749-55. PubMed ID: 10872560
[TBL] [Abstract][Full Text] [Related]
53. Angiotensin converting enzyme inhibitors suppress the vascular renin-angiotensin system of spontaneously hypertensive rats.
Higashimori K; Nakamaru M; Tabuchi Y; Nagano M; Mikami H; Ogihara T; Inagami T
Am J Hypertens; 1991 Jan; 4(1 Pt 2):56S-59S. PubMed ID: 2009150
[TBL] [Abstract][Full Text] [Related]
54. Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension.
Racasan S; Hahnel B; van der Giezen DM; Blezer EL; Goldschmeding R; Braam B; Kriz W; Koomans HA; Joles JA
Kidney Int; 2004 Feb; 65(2):575-81. PubMed ID: 14717927
[TBL] [Abstract][Full Text] [Related]
55. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin.
Santucci A; Leonetti Luparini R; Ferri C; Ficara C; Giarrizzo C; Balsano F
J Hypertens Suppl; 1985 Nov; 3(2):S133-4. PubMed ID: 3003302
[TBL] [Abstract][Full Text] [Related]
56. Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors.
Subissi A; Criscuoli M; Sardelli G; Guelfi M; Giachetti A
J Cardiovasc Pharmacol; 1992 Jul; 20(1):139-46. PubMed ID: 1383623
[TBL] [Abstract][Full Text] [Related]
57. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
Brown NJ; Agirbasli M; Vaughan DE
Hypertension; 1999 Aug; 34(2):285-90. PubMed ID: 10454455
[TBL] [Abstract][Full Text] [Related]
58. Comparative effects of captopril and l-carnitine on blood pressure and antioxidant enzyme gene expression in the heart of spontaneously hypertensive rats.
Miguel-Carrasco JL; Monserrat MT; Mate A; Vázquez CM
Eur J Pharmacol; 2010 Apr; 632(1-3):65-72. PubMed ID: 20123095
[TBL] [Abstract][Full Text] [Related]
59. Cardiovascular effects of inhibition of renin-angiotensin-aldosterone system components in hypertensive rats given salt excess.
Susic D; Varagic J; Frohlich ED
Am J Physiol Heart Circ Physiol; 2010 Apr; 298(4):H1177-81. PubMed ID: 20118410
[TBL] [Abstract][Full Text] [Related]
60. Feedback analysis of the behavior of the renin-angiotensin system under inhibition of angiotensin-converting enzyme.
Wada T; Aoyagi T; Iinuma H; Ogawa K; Kojima F; Nagai M; Kuroda H; Obayashi A; Takeuchi T
Biotechnol Appl Biochem; 1988 Oct; 10(5):435-46. PubMed ID: 3058152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
